1 / 16

Yaohai BioPharma Overview

Yaohai Bio-Pharma is the first and largest biologics CRDMO (Contract Research, Development and Manufacturing Organization) focusing on microbial expression systems in China. It provides customized end-to-end solutions from DNA design and synthesis, microbial strain engineering and construction to drug substance manufacturing in GMP or non-GMP level and products fill & finish across diversified modalities, such as recombinant proteins, peptides and polypeptides, enzymes, single-domain antibodies (sdAbs), plasmid DNA and mRNA, glyco-polymers, virus-like particles (VLPs), to meet global customers

Jiahui1
Télécharger la présentation

Yaohai BioPharma Overview

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Yaohai BioPharma

  2. About Us ◆ Founded in 2010, located in China Medical City ◆ The 1stand Largest microbial CRDMO, end-to-end solution provider in China ◆ 500 team members Services: ◆ Focus on recombinant proteins, peptides/polypeptides, enzymes, antibody fragments and single-domain antibodies (sdAbs), plasmid DNA and mRNA, China Medical City glyco-polymers, virus-like particles (VLPs) ◆ Meet global customers’ clinical and commercial needs in biological drugs, biosimilars, vaccines and diagnostics for human and animal health, aesthetic medicine Advantages : ◆cGMP Production Platform 7500+L ◆The Largest GMP-level Plasmid Supplier in China ◆Explosion-proof Facilities (High Potency Manufacturing Suite) ◆Bio-safety Level 2 (BSL-2) Lab for CDO ◆Allowing Customer PM/Technical Personnel to Be Stationed On-site

  3. Global Market CDMO Market Growth Rate by Region (2022-2027) Source: Mordor Intelligence Global CDMO Market By Cell Line Type $Million (2022) Source: www.psmarketresearch.com >50% 20-30%

  4. Position In The Industry The First and Largest CRDMO in Microbial Expression System Revenue in 5 years (USD, million) in China. 1 1 11.1 CAGR89% 7.63 3.89 3.20 Top 1 Number of serviced projects Top 1 Scale of 1.04 production capacity (7500+L） 2017 2018 2019 2020 2021

  5. Facilities G29 10, 000 m², in Production DS Workshop III：50-100L, DS Workshop IV：50-500L, DS Workshop V：50-200-500-2000L, DP Workshop II, Quality Control Center G27 8, 000 m², in Production DS Workshop I：50-500L, DS Workshop II：50-200-1000-2000L DP Workshop I FDA/EU Industrialization Standard Beijing Branch Process Development Center Nucleic Acid Drugs and Single-domain Antibodies CRO/CDO Quality Research Service

  6. Technical Capabilities Yaohai Bio-Pharma (Yaohai) concentrates on three principal technology areas: recombinant proteins, nucleic acid drugs and single-domain antibodies. Yaohai assists global biotech and pharmaceutical companies with all processes from R&D to commercial production, such as strain construction, analytical method development, process development, stability research, IND production for Phase I-III, registration & application, commercial manufacturing to serve customers with solutions for the whole process from Pre-IND to commercial production. Yaohai is engaged in providing efficient and feasible CDMO services and solutions to customers and facilitate the R&D of new drugs. Recombinant Protein Nucleic Acid Drug Single-domain Antibody (sdAb) End-to-end CDMO service platform for Focusing on the use of plasmid and mRNA, Global expression platform recombinant protein/polypeptide drugs accelerating the progress from R&D to clinical application Well experienced and equipped with LNP

  7. Expression Systems Yeast E. coli Tailor Constructed Strains Pichia pastoris, Hansenula polymorpha, Saccharomyces cerevisiae, etc. K-12 strains & derivatives (DH1, DH5α, RV308, W3110, MG1655, JM109, BW25113…) B strains (BL21, BL21(DE3), BL21(DE3) pLysS, BL21(DE3) Rosetta…) Other microbe/microbiota/microbiome provided by customers, such as customized protease-deficient engineered bacteria Yaohai has an integrated service platform from R&R to cGMP manufacturing to produce recombinant proteins, plasmids, and antibody fragments with expression systems of E.coli, yeast and customer-supplied or in-house engineered microbial strains.

  8. Service System ONE-STOP CRDMO Quality Management CTO CRO CDO CMO Microbial Strain Engineerin g and Constructi on Lab-scale Process Development & Optimization Commerci alized Productio n Selection of Nucleic Acid Drugs & Single- domain Antibodies GMP Quality Manag ement Process Scale-up &Optimiz ation Sample Production in Phase I/II/III Analytical Method Develop ment Registration & Application Quality Standard Research IND Applic ation Verific ation Stability Research Microbial Strain Engineering and Construction/Strain Bank Construction Process Development & Optimization Customized R&D Services Registration & Application Production in Phase I~III Commercial- ized Production IND Batches

  9. Cooperated Projects US-CN application 7 EU-CN application 1 AUS-CN application 2 CAN-CN application 1 Based on project phase Based on project type Recombinant antibody 7% IND 32% Recombinant peptide 3% Vaccine 8% Nanobodies 8% Recombinant protein 55% CircRNA 2% mRNA 8% Phase I 9% Pre-IND 53% DNA plasmid 9% Phase II 4% Recombinant protein CircRNA Recombinant peptide DNA plasmid Nanobodies Recombinant antibody mRNA Vaccine Phase III, 3%

  10. Core Services Strain Construction & Strain Bank Establishment Process Development & Optimization GMP Compliance Scale-up Production Method Development & Quality Control Strain construction Fermentation scale-up & Quality standards research Fermentation process ➢ ➢ ➢ ➢ GMP secondary strain library development & optimization production Method development & validation ➢ ➢ (WCB+MCB) establishment Purification scale-up & Sample commissioned testing Purification process ➢ ➢ ➢ development & optimization production Stability & compatibility ➢ Preparation production Preparation process research ➢ ➢ development & optimization Preparation of standards ➢ Related product preparation ➢

  11. Filling and Finishing Specification Range Maximum Output Workshop Equipment Dosage Form Filling speed: 1500m² Aseptic Pre-filled injectables Annual production: 2ml vial 160~300 vials/min, preparation workshop in Lyophilized powder injections 10 million injection (vials) 10ml vial 140~200 vials/min 1-25mL accordance with GMP Eye drops 5 million lyophilized Lyophilization capacity: requirements for Any Oral solutions powder for injection (vials) 2ml 37800 vials (4200 * 9 layers) Modalities (biologics, Inhalation formulations 10ml 20043 vials (2227 * 9 layers) vaccines, chemicals…)

  12. Equipment For Process Development 1 2 3 1 –Sartorius BIOSTAT C Full- automatic Bioreactor-30L 2 –Quadruple Fermentation System Made by Bioengineering AG -7L 3 – GE AKTA System 4 –BIO RAD Gel Imaging System 5 – qPCR Made by ThermoFisher 4 5 6 6 –SCIEX Capillary Electrophoresis;

  13. Equipment For Drug Substance Automatic buffer Configuration/storage system Fermentation system 00 L Disc centrifuge High pressure homogenizer Explosion-proof facilities/ RP system Sterility Isolator Hollow fiber system

  14. Equipment For QC HPLC Agilent 1260 Molecular Devices iD3 HPLC Thermo (U3000/Vanquish) QPCR ABI QuantStudio5 GC Agilent 8890

  15. Strategic Planning CRDMO Integration CDMO Aesthetic Medicine ◆ Extend service chain ◆ Based on the microbiology expression and cultivation ◆ Form CRO/CDMO integration ◆ Raw material and CDMO service integration ◆ Promote the comprehensive competitive ◆ Give full play to the comprehensive advantages of talent and advantage of technology and scale microbial track

  16. Website: https://www.yaohai-bio.com.cn/ Yaohai will live up to your trust！ Email: BD@yaohaibio.cn SERVE WITH HEART, CREATE THE FUTURE TOGETHER

More Related